4//SEC Filing
HANNAH ALISON L. 4
Accession 0001077183-24-000127
CIK 0001077183other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:24 PM ET
Size
16.5 KB
Accession
0001077183-24-000127
Insider Transaction Report
Form 4
HANNAH ALISON L.
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-10+11,336→ 118,769 total - Exercise/Conversion
Restricted Stock Unit
2024-08-10−11,336→ 0 totalExercise: $0.00From: 2024-08-10→ Common Stock (11,336 underlying)
Holdings
- 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,448
Stock Options (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying) - 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 13,882
Stock Option (Right to Buy)
Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying) - 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying)
Footnotes (2)
- [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
- [F2]Once vested, the shares of common stock are not subject to expiration.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001645600
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:24 PM ET
- Size
- 16.5 KB